Literature DB >> 11179143

Prognostic factors in prostate cancer.

R Montironi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11179143      PMCID: PMC1119620          DOI: 10.1136/bmj.322.7283.378

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  6 in total

Review 1.  Prostate cancer prevention: review of target populations, pathological biomarkers, and chemopreventive agents.

Authors:  R Montironi; R Mazzucchelli; J R Marshall; P H Bartels
Journal:  J Clin Pathol       Date:  1999-11       Impact factor: 3.411

Review 2.  Prognostic factors in prostate cancer. College of American Pathologists Consensus Statement 1999.

Authors:  D G Bostwick; D J Grignon; M E Hammond; M B Amin; M Cohen; D Crawford; M Gospadarowicz; R S Kaplan; D S Miller; R Montironi; T F Pajak; A Pollack; J R Srigley; J W Yarbro
Journal:  Arch Pathol Lab Med       Date:  2000-07       Impact factor: 5.534

Review 3.  Divergent neuroendocrine differentiation in prostatic carcinoma.

Authors:  P A di Sant' Agnese
Journal:  Semin Diagn Pathol       Date:  2000-05       Impact factor: 3.464

Review 4.  Precursors of prostatic cancer: progression, regression and chemoprevention.

Authors:  R Montironi; C C Schulman
Journal:  Eur Urol       Date:  1996       Impact factor: 20.096

5.  Vascular endothelial growth factor expression and capillary architecture in high-grade PIN and prostate cancer in untreated and androgen-ablated patients.

Authors:  R Mazzucchelli; R Montironi; A Santinelli; G Lucarini; A Pugnaloni; G Biagini
Journal:  Prostate       Date:  2000-09-15       Impact factor: 4.104

6.  Prostate cancer: are new prognostic markers on the horizon?

Authors:  M Lijovic; M E Fabiani; J Bader; A G Frauman
Journal:  Prostate Cancer Prostatic Dis       Date:  2000-08       Impact factor: 5.554

  6 in total
  3 in total

Review 1.  Histopathology reporting of prostate needle biopsies. 2005 update.

Authors:  Rodolfo Montironi; Remigio Vela Navarrete; Antonio Lopez-Beltran; Roberta Mazzucchelli; Gregor Mikuz; Aldo V Bono
Journal:  Virchows Arch       Date:  2006-04-22       Impact factor: 4.064

Review 2.  Carcinoma of the prostate: inherited susceptibility, somatic gene defects and androgen receptors.

Authors:  Rodolfo Montironi; Marina Scarpelli; Antonio López Beltran
Journal:  Virchows Arch       Date:  2004-03-26       Impact factor: 4.064

3.  Effectiveness and cost-effectiveness of prognostic markers in prostate cancer.

Authors:  N W Calvert; A B Morgan; J W F Catto; F C Hamdy; R L Akehurst; P Mouncey; S Paisley
Journal:  Br J Cancer       Date:  2003-01-13       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.